Mutanobactin D from the Human Microbiome: Total Synthesis, Configurational Assignment, and Biological Evaluation

• Published in: Journal of the American Chemical Society 2021-07, Vol.143 (27), p.10389-10402
• Main Authors: Pultar, Felix, Hansen, Moritz E, Wolfrum, Susanne, Böselt, Lennard, Fróis-Martins, Ricardo, Bloch, Susanne, Kravina, Alberto G, Pehlivanoglu, Deren, Schäffer, Christina, LeibundGut-Landmann, Salomé, Riniker, Sereina, Carreira, Erick M
• Format: Article
• Language: English
• Subjects: Antifungal Agents - chemistry; Antifungal Agents - pharmacology; Candida albicans - drug effects; Hyphae - drug effects; Models, Molecular; Peptides, Cyclic - chemical synthesis; Peptides, Cyclic - chemistry; Peptides, Cyclic - pharmacology
• ISSN: 0002-7863; 1520-5126
• DOI: 10.1021/jacs.1c04825

Mutanobactin D is a non-ribosomal, cyclic peptide isolated from Streptococcus mutans and shows activity reducing yeast-to-hyphae transition as well as biofilm formation of the pathogenic yeast Candida albicans. We report the first total synthesis of this natural product, which relies on enantioselective, zinc-mediated 1,3-dipolar cycloaddition and a sequence of cascading reactions, providing the key lipidated γ-amino acid found in mutanobactin D. The synthesis enables configurational assignment, determination of the dominant solution-state structure, and studies to assess the stability of the lipopeptide substructure found in the natural product. The information stored in the fingerprint region of the IR spectra in combination with quantum chemical calculations proved key to distinguishing between epimers of the α-substituted β-keto amide. Synthetic mutanobactin D drives discovery and analysis of its effect on growth of other members of the human oral consortium. Our results showcase how total synthesis is central for elucidating the complex network of interspecies communications of human colonizers.